Literature DB >> 31289167

ST elevation in recovery post exercise with normal coronary arteries.

Reza Aghamohammadzadeh1, Suhaib Magdi El-Omar2, Derek Rowlands3, Magdi El-Omar3.   

Abstract

We present the case of a 45-year-old healthy man who successfully completed three stages of the Bruce protocol but developed inferolateral ST segment elevation in the recovery phase. The ECG change was associated with a marked drop in blood pressure. He underwent emergency coronary angiography which revealed normal coronary arteries. It is likely that post-exercise hypotension triggered coronary spasm which caused the ST segment elevation. Alternatively, coronary spasm may have been the primary event, inducing sufficient myocardial ischaemia to cause a marked drop in blood pressure. Exercise tolerance testing is often a reliable test to rule out reversible myocardial ischaemia. While the physician is focused on ischaemic changes or rhythm abnormalities developing during the exercise phase, the recovery period is just as important and requires as much vigilance. Coronary vasospasm can result in significant ST changes and haemodynamic compromise at any point during the test, and the ECG traces can be indistinguishable from a classic ST elevation myocardial infarction, as in the present case. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  interventional cardiology; ischaemic heart disease

Mesh:

Substances:

Year:  2019        PMID: 31289167      PMCID: PMC6615783          DOI: 10.1136/bcr-2019-229766

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  17 in total

Review 1.  Postexercise hypotension and sustained postexercise vasodilatation: what happens after we exercise?

Authors:  John R Halliwill; Tahisha M Buck; Alisha N Lacewell; Steven A Romero
Journal:  Exp Physiol       Date:  2012-08-07       Impact factor: 2.969

2.  Clinical significance of early vs late hypotensive blood pressure response to treadmill exercise.

Authors:  G Watson; E Mechling; G A Ewy
Journal:  Arch Intern Med       Date:  1992-05

3.  Exercise-induced hypotension in a male population. Criteria, causes, and prognosis.

Authors:  P Dubach; V F Froelicher; J Klein; D Oakes; M Grover-McKay; R Friis
Journal:  Circulation       Date:  1988-12       Impact factor: 29.690

4.  Greater fluid loss does not fully explain the divergent hemodynamic balance mediating postexercise hypotension in endurance-trained men.

Authors:  Robert D Meade; Craig G Crandall; Daniel Gagnon; Glen P Kenny
Journal:  J Appl Physiol (1985)       Date:  2018-02-01

5.  Hypovolemia-induced severe coronary spasm leading to acute myocardial infarction.

Authors:  Hm Hadi; Sp D'souza; M El-Omar
Journal:  Exp Clin Cardiol       Date:  2012

6.  The significance of hypotension developing during treadmill exercise testing.

Authors:  R Levites; T Baker; G J Anderson
Journal:  Am Heart J       Date:  1978-06       Impact factor: 4.749

7.  Prognostic and predictive value of exertional hypotension in suspected coronary heart disease.

Authors:  K E Hammermeister; T A DeRouen; H T Dodge; M Zia
Journal:  Am J Cardiol       Date:  1983-05-01       Impact factor: 2.778

8.  Asymptomatic ST segment elevation in the recovery phase of the exercise stress test due to slow coronary flow.

Authors:  Murat Sunbul; Okan Erdogan; Ibrahim Sari
Journal:  Postepy Kardiol Interwencyjnej       Date:  2014-03-23       Impact factor: 1.426

9.  Coronary artery spasm: An often overlooked diagnosis.

Authors:  Oluwaseun Davies; Olumide Ajayeoba; Damian Kurian
Journal:  Niger Med J       Date:  2014-07

10.  Exercise-induced vasospastic angina with prominent ST elevation: a case report.

Authors:  Akinori Tamura; Kazuya Nagao; Tsukasa Inada; Masaru Tanaka
Journal:  Eur Heart J Case Rep       Date:  2018-11-24
View more
  1 in total

1.  Stress Echo 2030: The Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging.

Authors:  Eugenio Picano; Quirino Ciampi; Lauro Cortigiani; Adelaide M Arruda-Olson; Clarissa Borguezan-Daros; José Luis de Castro E Silva Pretto; Rosangela Cocchia; Eduardo Bossone; Elisa Merli; Garvan C Kane; Albert Varga; Gergely Agoston; Maria Chiara Scali; Doralisa Morrone; Iana Simova; Martina Samardjieva; Alla Boshchenko; Tamara Ryabova; Alexander Vrublevsky; Attila Palinkas; Eszter D Palinkas; Robert Sepp; Marco A R Torres; Hector R Villarraga; Tamara Kovačević Preradović; Rodolfo Citro; Miguel Amor; Hugo Mosto; Michael Salamè; Paul Leeson; Cristina Mangia; Nicola Gaibazzi; Domenico Tuttolomondo; Costantina Prota; Jesus Peteiro; Caroline M Van De Heyning; Antonello D'Andrea; Fausto Rigo; Aleksandra Nikolic; Miodrag Ostojic; Jorge Lowenstein; Rosina Arbucci; Diego M Lowenstein Haber; Pablo M Merlo; Karina Wierzbowska-Drabik; Jaroslaw D Kasprzak; Maciej Haberka; Ana Cristina Camarozano; Nithima Ratanasit; Fabio Mori; Maria Grazia D'Alfonso; Luigi Tassetti; Alessandra Milazzo; Iacopo Olivotto; Alberto Marchi; Hugo Rodriguez-Zanella; Angela Zagatina; Ratnasari Padang; Milica Dekleva; Ana Djordievic-Dikic; Nikola Boskovic; Milorad Tesic; Vojislav Giga; Branko Beleslin; Giovanni Di Salvo; Valentina Lorenzoni; Matteo Cameli; Giulia Elena Mandoli; Tonino Bombardini; Pio Caso; Jelena Celutkiene; Andrea Barbieri; Giovanni Benfari; Ylenia Bartolacelli; Alessandro Malagoli; Francesca Bursi; Francesca Mantovani; Bruno Villari; Antonello Russo; Michele De Nes; Clara Carpeggiani; Ines Monte; Federica Re; Carlos Cotrim; Giuseppe Bilardo; Ariel K Saad; Arnas Karuzas; Dovydas Matuliauskas; Paolo Colonna; Francesco Antonini-Canterin; Mauro Pepi; Patricia A Pellikka
Journal:  J Clin Med       Date:  2021-08-17       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.